Growth Metrics

Petmed Express (PETS) EBIAT (2016 - 2025)

Petmed Express has reported EBIAT over the past 16 years, most recently at -$10.6 million for Q4 2025.

  • For Q4 2025, EBIAT fell 1392.64% year-over-year to -$10.6 million; the TTM value through Dec 2025 reached -$64.9 million, down 18270.59%, while the annual FY2025 figure was -$6.3 million, 15.98% up from the prior year.
  • EBIAT for Q4 2025 was -$10.6 million at Petmed Express, down from -$8.5 million in the prior quarter.
  • Over five years, EBIAT peaked at $6.8 million in Q1 2021 and troughed at -$34.2 million in Q2 2025.
  • A 5-year average of -$1.8 million and a median of $251500.0 in 2022 define the central range for EBIAT.
  • On a YoY basis, EBIAT climbed as much as 430.46% in 2024 and fell as far as 2222.22% in 2024.
  • Year by year, EBIAT stood at $3.8 million in 2021, then crashed by 105.55% to -$212000.0 in 2022, then plummeted by 856.13% to -$2.0 million in 2023, then skyrocketed by 65.12% to -$707000.0 in 2024, then tumbled by 1392.64% to -$10.6 million in 2025.
  • Business Quant data shows EBIAT for PETS at -$10.6 million in Q4 2025, -$8.5 million in Q3 2025, and -$34.2 million in Q2 2025.